Search
Feed aggregator
BioSpace x DIA: Advanced Therapy Product Regulatory Confusion
BioSpace x DIA: Advanced Therapy Product Regulatory Confusion 5/30/2024
BioNTech Secures $145M to Boost mRNA Vaccine Capabilities in Africa
BioNTech Secures $145M to Boost mRNA Vaccine Capabilities in Africa 5/30/2024
Early-Stage Biotechs Now Tying CEO Pay Packages to Capital Raises
Early-Stage Biotechs Now Tying CEO Pay Packages to Capital Raises 5/30/2024
Moving Up: 5 Tips for Transitioning From Co-Worker to Manager
Moving Up: 5 Tips for Transitioning From Co-Worker to Manager 5/30/2024
Merck’s Potential $3B EyeBio Acquisition Puts Drugmaker Back in Ophthalmology
Merck’s Potential $3B EyeBio Acquisition Puts Drugmaker Back in Ophthalmology 5/29/2024
Amgen Wins FDA Approval for First Biosimilar to AstraZeneca’s Soliris
Amgen Wins FDA Approval for First Biosimilar to AstraZeneca’s Soliris 5/29/2024
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters 5/29/2024
Insmed Stock Surges After Brensocatib Aces Phase III Lung Disease Study
Insmed Stock Surges After Brensocatib Aces Phase III Lung Disease Study 5/29/2024
AstraZeneca’s Ambitious Target, Pharma Layoffs Continue and ASCO
AstraZeneca’s Ambitious Target, Pharma Layoffs Continue and ASCO 5/29/2024
Who Will the Next “Big Pharma” Players Be?
Who Will the Next “Big Pharma” Players Be? 5/29/2024
How Realistic is AstraZeneca’s $80B Revenue Target by 2030?
How Realistic is AstraZeneca’s $80B Revenue Target by 2030? 5/29/2024
J&J Scores Phase III Victory in Major Depressive Disorder
J&J Scores Phase III Victory in Major Depressive Disorder 5/29/2024
Biopharma IPOs From the First Half of 2024
Biopharma IPOs From the First Half of 2024 5/29/2024
Can AI Help Biopharma Companies Go Green?
Can AI Help Biopharma Companies Go Green? 5/29/2024
AstraZeneca Touts Early-Stage Results for Oral PCSK9 Inhibitor
AstraZeneca Touts Early-Stage Results for Oral PCSK9 Inhibitor 5/29/2024
J&J Inks $1.25B Deal to Buy Rights to Atopic Dermatitis Candidate from Numab
J&J Inks $1.25B Deal to Buy Rights to Atopic Dermatitis Candidate from Numab 5/28/2024
Asahi Kasei Offers $1.1B for Swedish Pharma Calliditas Therapeutics
Asahi Kasei Offers $1.1B for Swedish Pharma Calliditas Therapeutics 5/28/2024
AstraZeneca, Daiichi Sankyo ADC Misses Endpoint in Phase III NSCLC Study
AstraZeneca, Daiichi Sankyo ADC Misses Endpoint in Phase III NSCLC Study 5/28/2024
NS Pharma’s DMD Candidate Viltespo Fails Confirmatory Phase III Trial
NS Pharma’s DMD Candidate Viltespo Fails Confirmatory Phase III Trial 5/28/2024
Novo Nordisk’s Once-Weekly Insulin Loses FDA Adcomm Vote for Type 1 Diabetes
Novo Nordisk’s Once-Weekly Insulin Loses FDA Adcomm Vote for Type 1 Diabetes 5/28/2024
World Pharma News
- Innovative ‘poop pills’ show promising results in clinical trials for multiple types of cancer
- Sanofi announces the signing of a share buyback mandate for up to €1 billion
- How a heart medication could unlock a new targeted approach in lymphoma
- A broken DNA repair tool accelerates aging
- AstraZeneca begins trading on the New York Stock Exchange